Collagen is the most abundant protein in the human body. Vitamin C is required to make it. This is not a supplement claim — it is biochemistry. Here is the pathway, and what happens when it fails.
Collagen is the most abundant protein in the human body, comprising approximately 30% of total protein mass. It is the primary structural component of skin, tendons, ligaments, bone, and blood vessels. The synthesis of collagen is one of the most biochemically complex processes in human physiology — and it has an absolute requirement for vitamin C at two critical steps. This is not a nuanced claim about optimal dosing; it is a hard biochemical dependency. Without vitamin C, collagen synthesis fails. This is the mechanism of scurvy.
Collagen synthesis begins in the rough endoplasmic reticulum of fibroblasts. The cell transcribes and translates procollagen — a precursor protein consisting of three polypeptide chains (alpha chains) that must be assembled into a triple helix before secretion. The assembly of the triple helix requires two post-translational modifications: hydroxylation of proline residues (producing hydroxyproline) and hydroxylation of lysine residues (producing hydroxylysine). Both reactions are catalysed by iron-dependent dioxygenases — prolyl hydroxylase and lysyl hydroxylase — and both require vitamin C (ascorbic acid) as an essential cofactor.
The role of vitamin C is to maintain the iron in these enzymes in its reduced (Fe²⁺) state. During each catalytic cycle, the iron is oxidised to Fe³⁺ and must be reduced back to Fe²⁺ to allow the next reaction. Vitamin C donates electrons to accomplish this reduction. Without vitamin C, the enzymes become inactivated after a single catalytic cycle. Hydroxylation stops. The procollagen chains cannot form a stable triple helix. Unstable procollagen is degraded rather than secreted. Collagen synthesis effectively ceases.
Vitamin C is not a cofactor in the loose sense of 'helpful addition'. It is a stoichiometric reactant consumed in every catalytic cycle of prolyl and lysyl hydroxylase. Without it, the reaction does not proceed.
— Pullar JM et al., Nutrients, 2017
Hydroxyproline is found almost exclusively in collagen — it constitutes approximately 14% of collagen's amino acid composition. This makes it a useful biomarker: urinary hydroxyproline reflects collagen turnover, and plasma hydroxyproline-containing peptides (particularly GPH and PH) are the bioavailability markers used in collagen supplement trials. The fact that hydroxyproline is collagen-specific is a direct consequence of the vitamin C-dependent hydroxylation step — without this modification, the amino acid would simply be proline.
Vitamin C is not the only micronutrient required for collagen. After procollagen is secreted from the cell and cleaved to form tropocollagen, the collagen molecules must be cross-linked to form mature collagen fibrils. This cross-linking is catalysed by lysyl oxidase, a copper-dependent enzyme. Without adequate copper, lysyl oxidase cannot function, cross-linking fails, and the resulting collagen is structurally weak — the mechanism underlying the connective tissue fragility seen in Menkes disease (copper transport deficiency).
The biochemistry has direct implications for how collagen supplements should be formulated and used. Collagen peptide supplements provide the substrate (hydroxyproline-containing peptides that signal fibroblasts to synthesise new collagen) but they do not provide the cofactors required for that synthesis. A collagen supplement taken without adequate vitamin C is providing the raw material for a factory that lacks the essential reagent to operate.
This is the rationale for the combination trials. The 2024 Žmitek et al. RCT (n=87) combined 5 g hydrolysed collagen with 80 mg vitamin C and found significant improvements in dermis density, skin texture, and wrinkle severity. The vitamin C dose used (80 mg) is modest — close to the EU recommended daily intake — suggesting that even baseline adequacy, rather than high-dose supplementation, is sufficient to support the collagen synthesis pathway.
Scurvy — the clinical syndrome of vitamin C deficiency — is instructive because it demonstrates what happens when the collagen synthesis pathway fails systemically. The symptoms are a direct catalogue of collagen-dependent tissues: bleeding gums (gingival collagen), perifollicular haemorrhages (capillary collagen), joint pain (cartilage collagen), impaired wound healing (dermal collagen), and eventually cardiovascular collapse (vascular collagen). The syndrome develops within weeks of severe vitamin C depletion and reverses rapidly with repletion. No other nutrient deficiency produces this specific pattern of connective tissue failure.
Vitaei verdict
Vitamin C's role in collagen synthesis is not a supplement claim — it is established biochemistry with clinical consequences (scurvy) that have been documented for centuries. For skin specifically: adequate vitamin C intake (≥80 mg/day) is a prerequisite for collagen synthesis, not an optional enhancement. Collagen peptide supplements are most effective when vitamin C status is adequate. Topical vitamin C provides additional localised benefits for photoprotection and pigmentation. The combination of oral collagen peptides + vitamin C has Tier I RCT evidence for skin outcomes.
Collagen supplements: which forms are absorbed and which are not
Not all collagen is equal. The difference between a product that works and one that doesn't comes down to molecular weight, peptide composition, and what happens in the gut before any of it reaches your skin.
Skin ageing at the cellular level: the 12 hallmarks applied to skin
The same nine — now twelve — hallmarks that drive systemic ageing play out in skin with unusual visibility. Understanding them explains why some interventions work and most don't.
Astaxanthin vs vitamin C for skin: a head-to-head evidence review
Both are antioxidants. Both have RCT evidence for skin outcomes. But they work through different mechanisms, target different problems, and the evidence for each is stronger in different areas.